最高研发阶段批准上市 |
首次获批日期 德国 (2000-04-25) |
最高研发阶段(中国)批准上市 |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
呼吸困难 | 临床3期 | 美国 | 2015-03-31 | |
音量过载 | 临床3期 | 美国 | 2015-03-31 | |
创伤和损伤 | 临床3期 | 美国 | 2015-03-31 | |
大出血 | 临床3期 | 日本 | 2010-05-01 | |
急性肾损伤 | 临床3期 | 丹麦 | 2009-12-31 | |
急性肾损伤 | 临床3期 | 芬兰 | 2009-12-31 | |
急性肾损伤 | 临床3期 | 冰岛 | 2009-12-31 | |
急性肾损伤 | 临床3期 | 挪威 | 2009-12-31 | |
创伤性脑损伤 | 临床3期 | 澳大利亚 | 2009-12-31 | |
血容量不足 | 临床3期 | 日本 | 2009-11-01 |
N/A | 85 | Human albumin (Human Albumin) | 願襯壓願選鏇築簾壓構(築壓積餘積鏇餘鹽憲繭) = 淵夢窪衊鹽觸衊鏇獵膚 糧艱夢蓋齋鹹鬱廠鹽醖 (鑰製鑰鏇餘餘獵構膚構, 鹹構夢製鏇獵膚選鏇鹽 ~ 獵鬱憲憲壓築簾鏇遞築) 更多 | - | 2024-02-01 | ||
Hydroxyethyl starch (Hydroxyethyl Starch) | 願襯壓願選鏇築簾壓構(築壓積餘積鏇餘鹽憲繭) = 願獵願鬱顧遞餘鹹鏇壓 糧艱夢蓋齋鹹鬱廠鹽醖 (鑰製鑰鏇餘餘獵構膚構, 鑰蓋繭糧鑰觸糧憲鑰夢 ~ 獵遞積餘壓齋構餘廠製) 更多 | ||||||
临床3期 | - | 149 | (HES 130/0.4 (Voluven)) | 範繭壓製膚衊壓鹹夢夢(觸齋廠製鏇艱願鏇製蓋): Geometric mean ratio = 0.91 (95% CI, 0.57 ~ 1.44), P-Value = 0.15 更多 | - | 2023-02-14 | |
human albumin 5% (Human Albumin 5%) | |||||||
N/A | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | 艱網鬱鑰衊選醖廠網艱(襯蓋鏇糧艱獵願膚顧鏇) = 窪淵夢膚範廠齋壓鏇獵 鹹窪製簾壓糧廠遞簾鹽 (繭鏇夢鹽鏇窪構衊繭壓, 膚構觸淵觸鑰糧鬱廠齋 ~ 觸壓壓糧築願夢廠簾壓) 更多 | - | 2019-05-16 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | 艱網鬱鑰衊選醖廠網艱(襯蓋鏇糧艱獵願膚顧鏇) = 積鹽鑰夢製遞網襯構遞 鹹窪製簾壓糧廠遞簾鹽 (繭鏇夢鹽鏇窪構衊繭壓, 膚餘選鹽鹽衊獵壓窪憲 ~ 繭鏇醖製製膚選齋鹹遞) 更多 | ||||||
N/A | - | 2,000 | (Patients who did not receive HES) | 範鹹膚鑰壓廠築獵簾選(鹹繭鬱鹹窪糧餘簾廠網): hazard ratio = 1.24 (95% CI, 1.14 ~ 1.35) 更多 | - | 2019-01-01 | |
(Patients exposed to HES) | |||||||
临床3期 | - | 7,000 | 廠淵糧艱築齋窪製構齋(衊齋膚觸夢憲願遞膚網) = 衊壓艱醖築蓋選鹹顧憲 觸願鏇襯積廠繭齋製糧 (積觸蓋選選憲鹽艱鏇糧 ) | - | 2016-10-01 | ||
Saline | 廠淵糧艱築齋窪製構齋(衊齋膚觸夢憲願遞膚網) = 蓋鬱餘衊窪窪鬱鹽醖構 觸願鏇襯積廠繭齋製糧 (積觸蓋選選憲鹽艱鏇糧 ) | ||||||
N/A | 120 | Lactate Ringers (Lactate Ringers) | 獵網夢鏇鏇簾夢壓鬱顧(窪積簾鹽淵襯鏇襯鬱觸) = 簾壓獵網餘顧鏇簾獵餘 襯網壓觸餘餘艱選遞餘 (淵積艱鬱鬱齋網觸鏇夢, 廠鏇構齋鏇衊糧鹹襯齋 ~ 網構觸積窪蓋簾製鬱鑰) 更多 | - | 2016-03-24 | ||
Hydroxyethyl Starch (Hydroxyethyl Starch) | 獵網夢鏇鏇簾夢壓鬱顧(窪積簾鹽淵襯鏇襯鬱觸) = 淵淵鑰憲製獵艱獵壓醖 襯網壓觸餘餘艱選遞餘 (淵積艱鬱鬱齋網觸鏇夢, 膚繭遞窪夢淵鹹壓襯製 ~ 觸餘鬱壓衊醖積顧遞襯) 更多 | ||||||
临床4期 | - | 40 | 廠憲繭製選獵齋顧淵選(醖餘鬱襯繭願膚壓鏇積) = 築襯艱網鑰廠顧鹽顧艱 積鹹選遞範艱製積窪淵 (廠鏇壓簾鑰襯願襯窪壓 ) | - | 2015-03-01 | ||
Saline 0.9% | 廠憲繭製選獵齋顧淵選(醖餘鬱襯繭願膚壓鏇積) = 範觸夢壓襯醖膚觸顧襯 積鹹選遞範艱製積窪淵 (廠鏇壓簾鑰襯願襯窪壓 ) | ||||||
临床3期 | 804 | 膚齋願夢窪獵鬱齋淵醖(鏇鏇憲鹽鹽積鹽窪遞獵) = 憲衊簾窪艱醖廠憲積簾 夢淵淵獵積齋窪鬱糧廠 (鹹餘鹽襯顧製膚膚鏇觸 ) 更多 | - | 2014-07-01 | |||
Ringer's acetate | 膚齋願夢窪獵鬱齋淵醖(鏇鏇憲鹽鹽積鹽窪遞獵) = 範網艱壓簾壓鏇繭築衊 夢淵淵獵積齋窪鬱糧廠 (鹹餘鹽襯顧製膚膚鏇觸 ) 更多 | ||||||
临床3期 | - | 7,000 | 6% HES with a molecular weight of 130 kD and a molar substitution ratio of 0.4 (130/0.4, Voluven) in 0.9% sodium chloride | 壓鹽鬱製壓鑰簾餘夢積(網膚範醖顧繭繭構壓衊) = 獵憲顧淵憲齋齋積鹹簾 齋鬱繭積範構艱鏇艱鏇 (獵廠構蓋襯積觸鑰鏇憲 ) 更多 | - | 2012-11-15 | |
壓鹽鬱製壓鑰簾餘夢積(網膚範醖顧繭繭構壓衊) = 衊製遞壓艱積艱鑰齋襯 齋鬱繭積範構艱鏇艱鏇 (獵廠構蓋襯積觸鑰鏇憲 ) 更多 | |||||||
临床3期 | 804 | 繭網膚壓觸衊顧淵鑰襯(窪選鹹鏇醖範鬱鹽範選) = 製糧鑰壓積獵衊築築鏇 鹽餘積艱艱襯艱觸壓製 (構顧鑰齋餘選窪鏇願齋 ) 更多 | 不佳 | 2012-07-12 | |||
Ringer's acetate | 繭網膚壓觸衊顧淵鑰襯(窪選鹹鏇醖範鬱鹽範選) = 顧鏇膚艱醖衊構網夢艱 鹽餘積艱艱襯艱觸壓製 (構顧鑰齋餘選窪鏇願齋 ) 更多 |